biguanides has been researched along with Acquired-Immune Deficiency Syndrome Dementia Complex in 1 studies
Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Self, RL | 1 |
| Mulholland, PJ | 1 |
| Nath, A | 1 |
| Harris, BR | 1 |
| Prendergast, MA | 1 |
1 other study available for biguanides and Acquired-Immune Deficiency Syndrome Dementia Complex
| Article | Year |
|---|---|
The human immunodeficiency virus type-1 transcription factor Tat produces elevations in intracellular Ca2+ that require function of an N-methyl-D-aspartate receptor polyamine-sensitive site.
Topics: AIDS Dementia Complex; Animals; Biguanides; Brain; Calcium; Excitatory Amino Acid Antagonists; Femal | 2004 |